Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00823446 · ClinicalTrials.gov registry record · Phase 1
Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers
A Phase 1 study, sponsored by Revalesio Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT00823446 is a Phase 1 study that has completed, run by Revalesio Corporation. The registered enrollment target is 13 participants.
The verdict
NCT00823446, a Phase 1 study, has completed, sponsored by Revalesio Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to perform a preliminary evaluation of the safety of Revera Wound Care when topically applied to venous leg ulcers for 8 weeks of treatment.
Interventions
- DEVICE Revera Wound Care
- DEVICE Normal Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00823446
The ClinicalTrials.gov registry entry for NCT00823446 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Revalesio Corporation, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Revera Wound Care is the first listed.
NCT00823446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00823446 about?
NCT00823446 is a clinical study titled "Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers". The purpose of this study is to perform a preliminary evaluation of the safety of Revera Wound Care when topically applied to venous leg ulcers for 8 weeks of treatment.
What is the current status of trial NCT00823446?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2008-03. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00823446?
The interventions under investigation include: Revera Wound Care (DEVICE), Normal Saline (DEVICE).
Who is sponsoring clinical trial NCT00823446?
This trial is sponsored by Revalesio Corporation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.